Acuvue Oaysis Contact Lens Wearers Being Refit Into P7 Contact Lenses

ConditionContact Lens Comfort

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18-40

SponsorSouthern College of Optometry

About this trial

Determine the likelihood of successfully refitting a satisfied AOA CL wearers into P7A CLs

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Participants will be required to have worn AOA CLs for at least 3 months in the past year and currently wearing these CLs.

All participants will be required to have a CLDEQ-8 score <12 while wearing their habitual CLs (AOA CLs) and to indicate that they are satisfied with AOA CLs (Yes/No).

Participants will be required to be able to wear P7A CLs (astigmatism ≥0.75D OD/OS).

Astigmatism ranging from 0.75 D to 2.50 D in each eye

Disqualifiers

- Have presbyopia and/or need a reading add as determined during their initial manifest refraction

Have worn P7A in the past

Are past rigid CL wearers

Have a history of being diagnosed with dry eye or ocular allergies

Trial design

Design model

Single group

Treatments tested in this trial

Precision 7 contact lenses
Device
Acuvue Oaysis contact lens wearers have will be refit into precision 7 contact lenses.

Treatment groups

40 Participants

are divided into 1 treatment group

Group A: PRECISION7Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

Likert questionnaire

1\. Likelihood of continuing to wear P7A, 2. Overall satisfaction while wearing P7A, 3. Overall vision while wearing P7A, 4. End of day comfort while wearing P7A, 5. End of day vision while wearing P7A, 6. Overall comfort while wearing P7A, 7. Ability to play sports and perform fitness actives while wearing P7A, 8. Ability to use digital devices while wearing P7A (questions attached). 9. Would recommend the study CLs to a friend.

Time frame

1 week

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Southern College of Optometry

Lead sponsor

Eminent Ophthalmic Services

Collaborator

Source ClinicalTrials.gov

Apply now